Koyfin Home > Directory > Health Care > Antares Pharma > EV / EBITDA (ltm)

Antares Pharma EV / EBITDA (ltm) Chart (ATRS)

Antares Pharma annual/quarterly EV / EBITDA (ltm) from 2019 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Antares Pharma Market Cap for the quarter ending March 03, 2018 was $345m a -45.56% decrease of -157m year over year
  • Antares Pharma Price / Book for the quarter ending March 03, 2018 was 10.27 a -17.66% decrease of -1.81 year over year
  • Antares Pharma Enterprise Value for the quarter ending March 03, 2018 was $338m a -41.44% decrease of -140m year over year
View Chart On Koyfin